Not required by adverse drug reaction (ADR) reporting.

Not required by adverse drug reaction (ADR) reporting.

• A. careful selection of clinical trial participants
• B. recognition of events
• C. safety signals identified against a background of events
• D. accurate reporting

Answer: (A)

ADR reporting focuses on identifying when a patient experiences a possible drug-related event, documenting it thoroughly, and looking for safety signals within the pattern of other events. Recognizing events, detecting safety signals against a backdrop of background events, and reporting accurately are all essential parts of pharmacovigilance. Careful selection of clinical trial participants, while important for study design and safety, is not a function of the ADR reporting process itself. It happens to manage trial risk, not to fulfill reporting requirements.

ADR reporting focuses on identifying when a patient experiences a possible drug-related event, documenting it thoroughly, and looking for safety signals within the pattern of other events. Recognizing events, detecting safety signals against a backdrop of background events, and reporting accurately are all essential parts of pharmacovigilance. Careful selection of clinical trial participants, while important for study design and safety, is not a function of the ADR reporting process itself. It happens to manage trial risk, not to fulfill reporting requirements.